CurAegis (CRGS) 10-Q 9 Aug 19 2019 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2019	Aug. 09, 2019
Document Information [Line Items]
Entity Registrant Name	CurAegis Technologies, Inc.
Entity Central Index Key	0001063197
Trading Symbol	crgs
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Common Stock, Shares Outstanding (in shares)		50,698,674
Entity Shell Company	false
Document Type	10-Q
Document Period End Date	Jun. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q2
Amendment Flag	false
Title of 12(b) Security	Common Stock

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Current Assets:
Cash	$ 36,000	$ 53,000
Inventory (net)
Prepaid expenses and other current assets	4,000	25,000
Total current assets	40,000	78,000
Right to use building asset (net)	205,000
Property and equipment (net)	48,000	62,000
Software (net)	4,000	10,000
Total non-current assets	257,000	72,000
Total Assets	297,000	150,000
Current Liabilities:
Liability for Inventory Held at Vendor	1,477,000	1,462,000
Accounts payable	462,000	323,000
Promissory notes payable	425,000
Accrued interest	310,000	166,000
Senior convertible notes (net)	285,000
Current right-to-use obligation	147,000
Other current liabilities	48,000	40,000
Accrued wages and benefits	47,000	35,000
Total current liabilities	3,201,000	2,026,000
Non-current right-to-use obligation	102,000
Senior convertible notes (net)	7,387,000	6,603,000
Total Liabilities	10,690,000	8,629,000
Commitments and other matters
Stockholders' Deficiency:
Common stock, $.01 par value, 400,000,000 shares authorized; shares issued and outstanding at June 30, 2019 and December 31, 2018: 50,529,701 and 50,364,549, respectively	505,000	504,000
Additional paid-in capital	77,923,000	77,725,000
Accumulated deficit	(89,262,000)	(87,149,000)
Total Stockholders' Deficiency	(10,393,000)	(8,479,000)
Total Liabilities and Stockholders' Deficiency	297,000	150,000
Preferred Class C [Member]
Stockholders' Deficiency:
Preferred stock, value	157,000	157,000
Series C2 Preferred Stock [Member]
Stockholders' Deficiency:
Preferred stock, value	245,000	245,000
Series C3 Preferred Stock [Member]
Stockholders' Deficiency:
Preferred stock, value	33,000	33,000
Preferred Class A [Member]
Stockholders' Deficiency:
Preferred stock, value	5,000	5,000
Preferred Class B [Member]
Stockholders' Deficiency:
Preferred stock, value	$ 1,000	$ 1,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Jun. 30, 2019	Dec. 31, 2018
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	50,529,701	50,364,549
Common stock, shares outstanding (in shares)	50,529,701	50,364,549
Preferred Class C [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	15,687,500	15,687,500
Preferred stock, shares outstanding (in shares)	15,687,500	15,687,500
Series C2 Preferred Stock [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	24,500,000	24,500,000
Preferred stock, shares outstanding (in shares)	24,500,000	24,500,000
Series C3 Preferred Stock [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	3,268,000	3,268,000
Preferred stock, shares outstanding (in shares)	3,268,000	3,268,000
Preferred Class A [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0.40	$ 0.40
Preferred stock, shares issued (in shares)	468,221	468,221
Preferred stock, shares outstanding (in shares)	468,221	468,221
Preferred Class B [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0.50	$ 0.50
Preferred stock, shares issued (in shares)	67,500	67,500
Preferred stock, shares outstanding (in shares)	67,500	67,500

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenue and Cost of revenue:
CURA revenue	$ 2,000	$ 8,000	$ 9,000	$ 16,000
Cost of revenue	3,000	33,000	9,000	70,000
Loss on revenue	(1,000)	(25,000)		(54,000)
Costs and expenses:
Engineering and development	218,000	329,000	549,000	734,000
General and administrative	443,000	529,000	987,000	1,154,000
Total costs and expenses	661,000	858,000	1,536,000	1,888,000
Loss from operations	(662,000)	(883,000)	(1,536,000)	(1,942,000)
Non-operating expense:
Interest expense	(304,000)	(259,000)	(578,000)	(496,000)
Other income	1,000		1,000	1,000
Non-operating expense	(303,000)	(259,000)	(577,000)	(495,000)
Loss before income taxes	(965,000)	(1,142,000)	(2,113,000)	(2,437,000)
Income taxes
Net loss	(965,000)	(1,142,000)	(2,113,000)	(2,437,000)
Preferred stock dividends	54,000	54,000	108,000	108,000
Net loss attributable to common stockholders	$ (1,019,000)	$ (1,196,000)	$ (2,221,000)	$ (2,545,000)
Net loss per common share attributable to common stockholders
Basic and Diluted (in dollars per share)	$ (0.02)	$ (0.02)	$ (0.04)	$ (0.05)
Weighted average number of shares of common stock
Basic and Diluted (in shares)	50,478,000	49,571,000	50,456,000	49,302,000

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficiency) (Unaudited) - USD ($)	Conversion of Preferred C to Common Share [Member]Preferred Stock [Member]Series C Preferred Stock [Member]	Conversion of Preferred C to Common Share [Member]Common Stock [Member]	Conversion of Preferred C2 to Common Stock [Member]Preferred Stock [Member]Series C2 Preferred Stock [Member]	Conversion of Preferred C2 to Common Stock [Member]Common Stock [Member]	Conversion of Preferred C3 to Common Stock [Member]Preferred Stock [Member]Series C3 Preferred Stock [Member]	Conversion of Preferred C3 to Common Stock [Member]Common Stock [Member]	Preferred Stock [Member]Series C Preferred Stock [Member]	Preferred Stock [Member]Series C2 Preferred Stock [Member]	Preferred Stock [Member]Series C3 Preferred Stock [Member]	Preferred Stock [Member]Preferred Class A [Member]	Preferred Stock [Member]Preferred Class B [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Series C3 Preferred Stock [Member]	Total
Balance (in shares) at Dec. 31, 2017							15,937,500	25,000,000	3,388,000	468,221	67,500	48,979,546
Balance at Dec. 31, 2017							$ 159,000	$ 250,000	$ 34,000	$ 5,000	$ 1,000	$ 490,000	$ 76,494,000	$ (80,841,000)		$ (3,408,000)
Issuance of warrants with convertible note													208,000			208,000
Stock-based compensation													2,000			2,000
Net Loss														(1,295,000)		(1,295,000)
Conversion Preferred to common stock (in shares)									(80,000)			80,000
Conversion Preferred to common stock									$ (1,000)			$ 1,000
Beneficial conversion feature on convertible notes													11,000			11,000
Balance (in shares) at Mar. 31, 2018							15,937,500	25,000,000	3,308,000	468,221	67,500	49,059,546
Balance at Mar. 31, 2018							$ 159,000	$ 250,000	$ 33,000	$ 5,000	$ 1,000	$ 491,000	76,715,000	(82,136,000)		(4,482,000)
Balance (in shares) at Dec. 31, 2017							15,937,500	25,000,000	3,388,000	468,221	67,500	48,979,546
Balance at Dec. 31, 2017							$ 159,000	$ 250,000	$ 34,000	$ 5,000	$ 1,000	$ 490,000	76,494,000	(80,841,000)		(3,408,000)
Net Loss																(2,437,000)
Conversion Preferred to common stock (in shares)															870,000
Balance (in shares) at Jun. 30, 2018							15,687,500	24,500,000	3,268,000	468,221	67,500	49,849,546
Balance at Jun. 30, 2018							$ 157,000	$ 245,000	$ 33,000	$ 5,000	$ 1,000	$ 498,000	77,021,000	(83,278,000)		(5,318,000)
Balance (in shares) at Mar. 31, 2018							15,937,500	25,000,000	3,308,000	468,221	67,500	49,059,546
Balance at Mar. 31, 2018							$ 159,000	$ 250,000	$ 33,000	$ 5,000	$ 1,000	$ 491,000	76,715,000	(82,136,000)		(4,482,000)
Issuance of warrants with convertible note													223,000			223,000
Stock-based compensation													35,000			35,000
Net Loss														(1,142,000)		(1,142,000)
Conversion Preferred to common stock (in shares)	(250,000)	250,000	(500,000)	500,000	(40,000)	40,000
Conversion Preferred to common stock	$ (2,000)	$ 2,000	$ (5,000)	$ 5,000
Beneficial conversion feature on convertible notes													48,000			48,000
Balance (in shares) at Jun. 30, 2018							15,687,500	24,500,000	3,268,000	468,221	67,500	49,849,546
Balance at Jun. 30, 2018							$ 157,000	$ 245,000	$ 33,000	$ 5,000	$ 1,000	$ 498,000	77,021,000	(83,278,000)		(5,318,000)
Balance (in shares) at Dec. 31, 2018							15,687,500	24,500,000	3,268,000	468,221	67,500	50,364,549
Balance at Dec. 31, 2018							$ 157,000	$ 245,000	$ 33,000	$ 5,000	$ 1,000	$ 504,000	77,725,000	(87,149,000)		(8,479,000)
Issuance of warrants with convertible note													63,000			63,000
Stock-based compensation													59,000			59,000
Common Shares issued for interest (in shares)												35,996
Common Shares issued for interest													8,000			8,000
Net Loss														(1,148,000)		(1,148,000)
Balance (in shares) at Mar. 31, 2019							15,687,500	24,500,000	3,268,000	468,221	67,500	50,400,545
Balance at Mar. 31, 2019							$ 157,000	$ 245,000	$ 33,000	$ 5,000	$ 1,000	$ 504,000	77,855,000	(88,297,000)		(9,497,000)
Balance (in shares) at Dec. 31, 2018							15,687,500	24,500,000	3,268,000	468,221	67,500	50,364,549
Balance at Dec. 31, 2018							$ 157,000	$ 245,000	$ 33,000	$ 5,000	$ 1,000	$ 504,000	77,725,000	(87,149,000)		(8,479,000)
Net Loss																(2,113,000)
Balance (in shares) at Jun. 30, 2019							15,687,500	24,500,000	3,268,000	468,221	67,500	50,529,701
Balance at Jun. 30, 2019							$ 157,000	$ 245,000	$ 33,000	$ 5,000	$ 1,000	$ 505,000	77,923,000	(89,262,000)		(10,393,000)
Balance (in shares) at Mar. 31, 2019							15,687,500	24,500,000	3,268,000	468,221	67,500	50,400,545
Balance at Mar. 31, 2019							$ 157,000	$ 245,000	$ 33,000	$ 5,000	$ 1,000	$ 504,000	77,855,000	(88,297,000)		(9,497,000)
Issuance of warrants with convertible note													2,000			2,000
Stock-based compensation													45,000			45,000
Common Shares issued for interest (in shares)												39,156
Common Shares issued for interest													10,000			10,000
Net Loss														(965,000)		(965,000)
Common Shares issued with 2019 convertible notes (in shares)												90,000
Common Shares issued with 2019 convertible notes												$ 1,000	11,000			12,000
Balance (in shares) at Jun. 30, 2019							15,687,500	24,500,000	3,268,000	468,221	67,500	50,529,701
Balance at Jun. 30, 2019							$ 157,000	$ 245,000	$ 33,000	$ 5,000	$ 1,000	$ 505,000	$ 77,923,000	$ (89,262,000)		$ (10,393,000)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows used in operating activities:
Net loss	$ (2,113,000)	$ (2,437,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount reported as interest	351,000	289,000
Stock-based compensation	104,000	37,000
Depreciation and amortization	72,000	88,000
Interest paid in common stock	18,000
Changes in working capital items:
Accounts receivable		7,000
Inventory		3,000
Prepaid expenses and other current assets	21,000	(22,000)
Liability for inventory	15,000
Accounts payable	134,000	55,000
Accrued interest	144,000	78,000
Accrued wages and benefits	12,000	(202,000)
Other accrued liabilities		8,000
Net cash used in operating activities	(1,242,000)	(2,096,000)
Cash flows from financing activities:
Proceeds from issuance of senior convertible note	800,000	1,991,000
Proceeds from issuance of unsecured subordinated notes	425,000
Net cash provided by financing activities	1,225,000	1,991,000
Net decrease in cash	(17,000)	(105,000)
Cash at beginning of period	53,000	194,000
Cash at end of period	36,000	89,000
Supplemental Disclosures:
Right to use asset	257,000
Cash used for payment of interest expense	64,000	128,000
Debt discount related to issuance of convertible notes	$ 65,000	$ 494,000

Note 1 - The Company and Basis

Note 1 - The Company and Basis of Presentation	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1 CurAegis Technologies, Inc. (“CurAegis”, “the Company”) was incorporated as a New York business corporation in September 1996 2016 two The Company develops and markets advanced technologies in the areas of safety, wellness and power. The Company is focused on the commercialization of a wellness and safety system (the CURA System) and a uniquely designed hydraulic pump that will be smaller, lighter, less expensive and more efficient than current technology. The Company has not The Company has created the CURA System to market products that reduce fatigue risk in the workplace and help individuals manage their sleep and improve alertness. The CURA System consists of the following capabilities: ● real-time alertness utilizing the CURA app, ● the Group Wellness Index and ● the Z-Coach wellness program. The Aegis hydraulic pump technology has been designed to bring to the marketplace a unique concept in hydraulic pumps and motors that will be: ● smaller, lighter and less expensive than conventional pumps and motors, ● more efficient, ● as reliable, and ● unique in its ability to scale larger, allowing more powerful pumps and motors. It is important to note, regarding both the CURA and Aegis products, that the cycle time from the initiation of the sales process to revenue realization can be highly variable especially as a start-up entity. In addition to the activities to be undertaken to implement our plan of operations, we may Current Cash Outlook and Management Plans As of June 30, 2019, $36,000, $3,161,000, $10,393,000 $89,262,000. six June 30, 2019 $1,225,000 Management estimates that the 2019 $2.5 $3 first 2019. June 30, 2019, not Since inception, we have financed our operations by the sale of our securities and debt financings. We need to raise additional funds to meet our working capital needs, to fund expansion of our business, to complete development, testing and marketing of our products, or to make strategic acquisitions or investments. No may not The Company’s ability to fund its current and future commitments from its available cash depends on a number of factors. These factors include the Company’s ability to (i) launch and generate sales from the CURA division; (ii) generate revenue from the monetization of our hydraulic technologies; or (iii) decrease engineering and development and administrative expenses. If these and other factors are not no

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE 2 Basis of Presentation: The Company’s unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the instructions to Form 10 -Q and Article 8 - 03 of Regulation S- X of the Securities and Exchange Commission (“SEC”). Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of the Company’s management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included. The results for interim periods are not necessarily indicative of what the results will be for the fiscal year. The accompanying condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2018 contained in the Company’s 2018 Annual Report on Form 10 -K filed with the SEC. Consolidation: The condensed consolidated financial statements include the accounts of the Company, our wholly-owned subsidiary Iso-Torque Corporation, and our majority-owned subsidiary, Ice Surface Development, Inc. ( 56% owned). As of June 30, 2019, each of the subsidiaries is non-operational. Use of Estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. These estimates are subject to a high degree of judgment and potential change. Actual results could differ from those estimates. Reclassifications: Certain reclassifications may have been made to prior year balances to conform to the current year’s presentation. Cash: We maintain cash at financial institutions which periodically may exceed federally insured amounts. We have a corporate credit card program through our primary financial institution, JPMorgan Chase Bank, N.A. In connection with this, the Company granted a security interest to the bank in our money market account to act as collateral for the activity within the corporate card program, up to $5,000. Inventory : Inventory is stated at the lower of cost or net realizable value with cost determined under the average cost method. We have recorded provisions for excess, obsolete or slow-moving inventory based on changes in customer demand and technology developments. Inventory on hand at June 30, 2019 and December 31, 2018 has been fully reserved reflecting a reserve of $ 1,747,000 . Depreciation and amortization: Depreciation and amortization are computed using the straight-line method. Depreciation and amortization expense for the three and six months ended June 30, 2019 and 2018 are as follows: Three months ended June 30, 2019 Six months ended June 30, 2019 Three months ended June 30, 2018 Six months ended June 30, 2018 Right-to use building $ 25,000 $ 52,000 - - Software 2,000 6,000 $ 31,000 $ 62,000 Property and equipment 7,000 14,000 13,000 26,000 $ 34,000 $ 72,000 $ 44,000 $ 88,000 Right to use building asset: The FASB issued ASU No. 2016 - 02, “Leases,” which requires a lessee to recognize on its balance sheet the assets and liabilities related to long-term leases that were classified as operating leases under previous guidance. An asset is recognized related to the Company's ability to retain the economic benefits and control of the underlying asset. A corresponding liability is recognized related to the Company's obligation to make lease payments over the term of the lease. The standard became effective for the Company January 1, 2019. The Company utilized the modified retrospective approach to measure the right to use operating lease agreement associated with the office building used for our business operations located in Rochester, New York and utilized the practical expedient to not separate lease components from non-lease components. The adoption of this accounting standard did not impact our consolidated loss from operations and had no impact on cash flows. Software, Property and Equipment: Capitalized software, property and equipment are stated at cost. Estimated useful lives are as follows: Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term Betterments, renewals and significant repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense). Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may be indicated. The carrying amount is compared to the estimated discounted cash flows and if there is an excess such amount is recorded as impairment. Fair Value of Financial Instruments: As defined by U.S. GAAP , fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A hierarchy for ranking the quality and reliability of the information is used to determine fair values. Assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data Level 3: Unobservable inputs that are not corroborated by market data The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The Financial Accounting Standards Board’s (“FASB”) guidance for the disclosure about fair value of financial instruments requires disclosure of an estimate of the fair value of certain financial instruments. The fair value of financial instruments pursuant to FASB’s guidance for the disclosure about fair value of financial instruments approximated their carrying values at June 30, 2019 and December 31, 2018. The carrying amount of cash, prepaid expenses and other current assets, accounts payable, and accrued expenses approximates their fair value due to their short maturity. The senior convertible notes can be converted into common stock with an underlying value of $4,354,000 as of June 30, 2019 based on the trading price on June 30, 2019. Revenue Recognition and Deferred Revenue: On January 1, 2018, the Company adopted FASB ASC 606, "Revenue from Contracts with Customers" and all related amendments for all contracts using the modified retrospective method. There was no impact upon the adoption of ASC 606. For contracts where performance obligations are satisfied at a point in time, the Company recognizes revenue when the product is shipped to the customer. For contracts where the performance obligation is satisfied over time, as in the Z-Coach sales, the Company recognizes revenue over the subscription period. Revenue from the sale of the Company's products is recognized net of cash discounts, sales returns and allowances. The Company has two sources of revenue: (i) from the sale of CURA System products and (ii) from stand-alone Z-Coach subscriptions. The Company's net revenue is derived primarily from domestic customers. For the six months ended June 30, 2019 net revenue from products transferred over time amounted to $9,000 and there was no revenue from products transferred at a point in time. For the three months ended June 30, 2019 net revenue from products transferred over time amounted to $2,000 and there was no revenue from products transferred at a point in time. One customer accounted for 100% of total Z-Coach subscription sales made during the three months ended June 30, 2019. Our collection terms provide customers standard terms of net 30 days. Future performance obligations are reflected in deferred revenue. CURA revenue is recognized (a) upon receipt of payment at the point of sale of the CURA app, (b) upon the delivery of myCadian products and (c) upon the company’s satisfaction of all performance obligations as described in customer agreements. The Z-Coach Program provides fatigue training over an annual subscription period of twelve months. The Z-Coach Program allows the user unlimited access during the annual subscription period. Customers are billed at the acceptance of the subscription, and revenue is recognized ratably over the subscription period as our performance obligations are satisfied and when collection is reasonably assured. Our collection terms provide customers standard terms of net 30 days. Future performance obligations are reflected in deferred revenue. Engineering and Development and Patents: Engineering and development costs and patent expenses are charged to operations as incurred. Engineering and development include personnel-related costs, materials and supplies, depreciation and consulting services. Patent costs for the six months ended June 30, 2019 and 2018 amounted to $21,000 and $56,000, respectively, and are included in general and administrative expenses. Patent costs for the three months ended June 30, 2019 and 2018 amounted to $11,000 and $25,000, respectively, and are included in general and administrative expenses. Stock-based Compensation: FASB Accounting Standards Codification (“ASC”) 718 - 10 requires all share-based payments to be recognized as compensation expense over the service period (generally the vesting period) in the consolidated financial statements based on their fair values on the grant date. The impact of forfeitures that may occur prior to vesting is also estimated and considered in the amount recognized. In addition, the realization of tax benefits in excess of amounts recognized for financial reporting purposes will be recognized as a financing activity in accordance with ASC 718 - 10. No tax benefits were attributed to the stock-based compensation expense because a valuation allowance was maintained for substantially all net deferred tax assets. During 2018, the Company adopted FASB ASU 2018 - 07, “Equity-Based Payments to Non-Employees,” which requires all share-based payments to non-employees, including grants of stock options, to be recognized in the consolidated financial statements as expense generally over the service period of the consulting arrangement or as performance conditions are expected to be met. FASB ASC 718 - 20 requires that modifications of the terms or conditions of equity awards be treated as an exchange of the original award for a new award. Incremental compensation cost is measured as the excess, if any, of the fair value of the modified award over the fair value of the original award immediately before its terms are modified. The Company utilized a modified retrospective approach effective as of January 1, 2018 in the adoption of this accounting guidance which resulted in a reduction of $10,000 in stock compensation expense previously recorded costs for options outstanding to non-employees. Income Taxes: We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax basis of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than not that some portion or all of the deferred tax assets will not be realized. We account for uncertain tax positions using a more-likely-than- not recognition threshold based on the technical merits of the tax position taken. Tax benefits that meet the more-likely-than- not recognition threshold should be measured as the largest amount of tax benefits, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement in the financial statements. It is our policy to recognize interest and penalties related to income tax matters as general and administrative expenses. As of June 30, 2019, and December 31, 2018, there were no accrued interest or penalties related to uncertain tax positions. Loss per Common Share: FASB’s ASC 260 - 10 (“Earnings Per Share”) requires the presentation of basic earnings per share, which is based on weighted average common stock outstanding, and dilutive earnings per share, which gives effect to options, warrants and convertible securities in periods when they are dilutive. At June 30, 2019 and 2018, we excluded 99,159,056 and 87,941,132 potential common shares, respectively, relating to convertible preferred stock, convertible notes, options and warrants outstanding from the diluted net loss per common share calculation because their inclusion would be anti-dilutive. In addition, we excluded 625,000 warrants from the diluted net loss per common share calculation at June 30, 2019 and 2018 as the conditions for their vesting are not time-based.

Note 3 - Inventory and Related

Note 3 - Inventory and Related Vendor Liability	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Inventory Disclosure [Text Block]	NOTE 3 The Company had the following inventory produced by our manufacturing vendor as of June 30, 2019 December 31, 2018: June 30, 2019 December 31, 2018 Raw materials $ 1,678,000 $ 1,678,000 Finished goods 69,000 69,000 1,747,000 1,747,000 Less: Reserve for quality (1,747,000 ) (1,747,000 ) Inventory (net) $ - $ - Liability for inventory $ 1,477,000 $ 1,462,000 During 2017, third $1,747,000 $1,477,000

Note 4 - Senior Convertible Not

Note 4 - Senior Convertible Notes and Warrants	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 4 - SENIOR CONVERTIBLE NOTES At June 30, 2019, $9,960,000 $2,288,000, $7,672,000. December 31, 2018, $9,160,000 $2,557,000 $6,603,000. Scheduled maturities on the Company’s convertible note are: $300,000 twelve December 31, 2019, none 2020; $2,990,000 twelve December 31, 2021; $2,775,500 twelve December 31, 2022; $3,395,000 twelve December 31, 2023 $500,000 Included in the face value of convertible notes outstanding at June 30, 2019 December 31, 2018, $ 2,252,500 six $1,170,000 Total 2019 6% Notes JULY 2018 Notes 2018 Notes 2017 6% Notes 2016 6% Notes Face value December 31, 2018 $ 9,160,000 $ - $ 1,175,000 $ 625,000 $ 4,370,000 $ 2,990,000 Notes issued in current period 800,000 300,000 500,000 - - - Face value June 30, 2019 $ 9,960,000 $ 300,000 $ 1,675,000 $ 625,000 $ 4,370,000 $ 2,990,000 Debt discount December 31, 2018 $ (2,557,000 ) $ - $ (360,000 ) $ (231,000 ) $ (456,000 ) $ (1,510,000 ) Debt discount issued in current period (82,000 ) (17,000 ) (65,000 ) - - - Amortization of discount reported as interest 351,000 3,000 32,000 22,000 41,000 253,000 Debt discount June 30, 2019 $ (2,288,000 ) $ (14,000 ) $ (393,000 ) $ (209,000 ) $ (415,000 ) $ (1,257,000 ) Senior Convertible Notes (net) $ 7,672,000 $ 286,000 $ 1,282,000 $ 416,000 $ 3,955,000 $ 1,733,000 2019 In April 2019, $2.5 6% “2019 May 28, 2019 “2019 2019 five five The conversion rate of the notes is fixed at the greater of: $0.15 2019 30,000 $100,000 2019 The 2019 4 2 1933 506 501 The Company issued $300,000 2019 90,000 second 2019 $5,000 2019 three June 30, 2019, $4,000 $3,000 JULY 2018 In July 2018, $2.5 “JULY 2018 July 24, 2018 “JULY 2018 JULY 2018 five April 2019, The conversion rate of the notes was fixed at $0.25 July 24, 2018. 10% 25% $0.25 ten 4 2 1933 506 501 During the three June 30, 2019 June 30, 2018, $19,000 zero six June 30, 2019, $500,000 $65,000 six June 30, 2019 June 30, 2018, $32,000 zero 2018 In May 2018, $1 “2018 May 8, 2018 “2018 2018 five July 19, 2018, The conversion rate of the notes was fixed at $0.25 May 8, 2018. 10% 25% $0.25 ten 4 2 1933 506 501 During the three June 30, 2019 June 30, 2018, $11,000 $2,000 six June 30, 2019 June 30, 2018, $22,000 $2,000, 2017 The board of directors authorized the issuance of up to $5 6% “2017 May 31, 2017 “2017 2017 five 6%. 10% 25% The conversion rate of the 2017 $0.50 November 2018 $0.333 2017 November 2018 $0.333 The 2017 4 2 506 501 During the three June 30, 2019 June 30, 2018 $91,000 $92,000, $26,000 $28,000, six June 30, 2019 June 30, 2018, $171,000 $166,000, $41,000 48,000, 2016 During 2016, $3 6% “2016 August 25, 2016 “2016 2016 five August 2021 December 2021 6%. The conversion rate of the notes was fixed at $0.25 August 25, 2016. 10% $0.25 ten 4 2 1934, 506 501 1933. During the three June 30, 2019 June 30, 2018 $172,000 $165,000, $127,000 $120,000, six June 30, 2019 June 30, 2018, $342,000 $328,000, $253,000 $238,000,

Note 5 - Unsecured Subordinated

Note 5 - Unsecured Subordinated Promissory Notes	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Short-term Debt [Text Block]	NOTE 5 - UNSECURED SUBORDINATED PROMISSORY NOTES During the six June 30, 2019, $425,000 6% ninety

Note 6 - Right-to-use Building

Note 6 - Right-to-use Building Asset	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	NOTE 6 - RIGHT TO USE BUILDING ASSET The FASB issued ASU No. 2016 02, January 1, 2019. not no The Company measured the present value of future lease costs at $257,000, January 1, 2019. 6% not one May 2021. Operating lease costs for the first second 2019 $30,000 2019: $105,000, $114,000 2020 $47,000 2021. $267,000 $20,000.

Note 7 - Software

Note 7 - Software	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Research, Development, and Computer Software Disclosure [Text Block]	NOTE 7 - SOFTWARE The Company investments in software for the CURA system are amortized over an estimated useful life of 3 3 June 30, 2019 December 31, 2018 $4,000 $10,000, $4,000 2019.

Note 8 - Property and Equipment

Note 8 - Property and Equipment	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 8 - PROPERTY AND EQUIPMENT At June 30, 2019 December 31, 2018 June 30, 2019 December 31, 2018 Office equipment $ 249,000 $ 249,000 Shop equipment 182,000 182,000 Leasehold improvements 253,000 253,000 684,000 684,000 Less accumulated depreciation (636,000 ) (622,000 ) Net property and equipment $ 48,000 $ 62,000

Note 9 - Business Segments

Note 9 - Business Segments	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	NOTE 9 - BUSINESS SEGMENTS The Company has two Segment information for the three June 30, 2019 CURA Aegis Corporate Total Revenue $ 2,000 $ - $ - $ 2,000 Loss on revenue (1,000 ) - - (1,000 ) Total costs and expenses 176,000 150,000 335,000 661,000 Loss from operations (177,000 ) (150,000 ) (335,000 ) (662,000 ) Interest and other - - (303,000 ) (303,000 ) Net loss $ (177,000 ) $ (150,000 ) $ (638,000 ) $ (965,000 ) Stock based compensation $ 6,000 $ 5,000 $ 34,000 $ 45,000 Depreciation and amortization $ 3,000 $ 5,000 $ 26,000 $ 34,000 Assets at June 30, 2019 $ 6,000 $ 45,000 $ 246,000 $ 297,000 Segment information for the six June 30, 2019 CURA Aegis Corporate Total Revenue $ 9,000 $ - $ - $ 9,000 Loss on revenue - - - - Total costs and expenses 515,000 319,000 702,000 1,536,000 Loss from operations (515,000 ) (319,000 ) (702,000 ) (1,536,000 ) Interest and other - - (577,000 ) (577,000 ) Net loss $ (515,000 ) $ (319,000 ) $ (1,279,000 ) $ (2,113,000 ) Stock based compensation $ 14,000 $ 13,000 $ 77,000 $ 104,000 Depreciation and amortization $ 9,000 $ 10,000 $ 53,000 $ 72,000 Assets at June 30, 2019 $ 6,000 $ 45,000 $ 246,000 $ 297,000 Segment information for the three June 30, 2018 CURA Aegis Corporate Total Revenue $ 8,000 $ - $ - $ 8,000 Loss on revenue (25,000 ) - - (25,000 ) Total costs and expenses 373,000 160,000 325,000 858,000 Loss from operations (398,000 ) (160,000 ) (325,000 ) (883,000 ) Interest and other expense - - (259,000 ) (259,000 ) Net loss $ (398,000 ) $ (160,000 ) $ (584,000 ) $ (1,142,000 ) Stock based compensation $ 5,000 $ 26,000 $ 4,000 $ 35,000 Depreciation and amortization $ 37,000 $ 5,000 $ 2,000 $ 44,000 Assets at June 30, 2018 $ 1,810,000 $ 65,000 $ 144,000 $ 2,019,000 Segment information for the six June 30, 2018 CURA Aegis Corporate Total Revenue $ 16,000 $ - $ - $ 16,000 Loss on revenue (54,000 ) - - (54,000 ) Total costs and expenses 896,000 291,000 701,000 1,888,000 Loss from operations (950,000 ) (291,000 ) (701,000 ) (1,942,000 ) Interest and other expense - - (495,000 ) (495,000 ) Net loss $ (950,000 ) $ (291,000 ) $ (1,196,000 ) $ (2,437,000 ) Stock based compensation $ (11,000 ) $ 28,000 $ 20,000 $ 37,000 Depreciation and amortization $ 74,000 $ 10,000 $ 4,000 $ 88,000 Assets at June 30, 2018 $ 1,810,000 $ 65,000 $ 144,000 $ 2,019,000

Note 10 - Preferred and Common

Note 10 - Preferred and Common Stock	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	NOTE 1 0 - PREFERRED and COMMON STOCK Common Stock We have authorized 400,000,000 $0.01 During the six June 30, 2019 75,152 $0.25 2016 2017 90,000 2019 six June 30, 2018 870,000 Preferred Stock Our certificate of incorporation permits the Company to issue up to 100,000,000 $.01 Class A Preferred Stock At June 30, 2019 December 31, 2018 468,221 8,709 no 459,512 $2,621,000 June 30, 2019 $2,530,000 December 31, 2018. In the event of a liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred stockholders, Class A Preferred stockholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class A Preferred stockholders’ liquidation preference was $2,621,000 $2,530,000 June 30, 2019 December 31, 2018, 1 $4.00 Class B Preferred Stock At June 30, 2019 December 31, 2018, 67,500 $471,000 June 30, 2019 $454,000 December 31, 2018. In the event of liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred stockholders and our Class A Preferred stockholders, Class B Preferred stockholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class B Preferred stockholders’ liquidation preference was $471,000 $454,000 June 30, 2019 December 31, 2018, 1 $5.00 Series C Preferred Stock At June 30, 2019 December 31, 2018, 15,687,500 $6,275,000 June 30, 2019 December 31, 2018. The Series C Preferred shares have a liquidation preference at their stated value per share of $0.40 The Series C Preferred shares have no no Series C- 2 Preferred Stock At June 30, 2019 December 31, 2018, 24,500,000 2 2 $4,900,000 June 30, 2019 December 31, 2018. The Series C- 2 not no 2 may not, two 2 2 2 2 2 2 2 2 not Series C- 3 Preferred Stock At June 30, 2019 December 31, 2018, 3,268,000 3

Note 11 - Stock Options

Note 11 - Stock Options	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Share-based Payment Arrangement [Text Block]	NOTE 1 1 - STOCK OPTIONS 2016 Stock Option Plan 2016 “2016 3,000,000 may 2016 June 30, 2019, 1,220,000 2016 1,780,000 2011 Stock Option Plan 2011 “2011 3,000,000 may 2011 June 30, 2019, 91,500 2011 Under the 2016 2011 may may may not 10% may not 110% ten 10% may not five During the three six June 30, 2019, no three six June 30, 2018, 917,500 1,067,500 Summary three six June 30, 2019 $45,000 $104,000, three six June 30, 2018 $35,000 $37,000, June 30, 2019, $193,000 1.0 The weighted average grant date fair value of stock options granted during the six June 30, 2019 2018 zero $0.25, six June 30, 2019 2018 $74,000 $259,000, The fair value of each option granted was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: 2019 2018 Expected term (years) - 6.3 Expected forfeiture rate - 0% Risk-free rate - 2.6% Volatility - 130% Dividend yield - 0.0% The average risk-free interest rate is based on the U.S. treasury security rate in effect as of the grant date. We determined expected volatility using the historical closing stock price. The expected life was generally determined using the simplified method as we do not The following summarizes the activity of all of our outstanding stock options for the six June 30, 2019: Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term (years) Value Outstanding at January 1, 2019 11,028,500 $ 0.49 3.8 $ 94,000 Granted - - Exercised - - Canceled or expired - - Outstanding at June 30, 2019 11,028,500 $ 0.49 3.3 $ - Exercisable at June 30, 2019 7,314,000 $ 0.56 2.7 $ - During the six June 30, 2019, no six June 30, 2018, no 391,875 June 30, 2019, $.22 $1.58

Note 12 - Warrants

Note 12 - Warrants	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Stockholders Equity Note Warrants Or Rights [Text Block]	NOTE 1 2 - WARRANTS The following summarizes the activity of our outstanding warrants for the six June 30, 2019: Weighted Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 1, 2019 7,381,707 $ 0.46 (A) 7.0 (B) $ 39,000 Granted 350,000 0.25 Exercised - - Canceled or expired - - Outstanding at June 30, 2019 7,731,707 $ 0.45 (A) 6.7 (B) $ 27,000 Exercisable at June 30, 2019 7,106,707 $ 0.44 6.2 (C) $ 27,000 (A) The weighted average exercise price for warrants outstanding as of June 30, 2019 2018 1,750,000 no (B) The weighted average remaining contractual term for warrants outstanding as of June 30, 2019 2018 743,500 no (C) The weighted average remaining contractual term for warrants exercisable as of June 30, 2019, 2018 118,500 no

Note 13 - Related Party Transac

Note 13 - Related Party Transactions	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 1 3 - RELATED PARTY TRANSACTIONS As of June 30, 2019, December 31, 2018, $2,252,500 six 7,888,378 June 30, 2019 December 31, 2018. 1,239,288 June 30, 2019 December 31, 2018. During the first 2019, $425,000 ninety 6%

Note 14 - Subsequent Events

Note 14 - Subsequent Events	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 1 4 - SUBSEQUENT EVENTS Unsecured Subordinated Promissory Note with Related Party On July 11, 2019, $50,000 October 9, 2019. 6% Common shares Issued in Payment of Interest Expense Subsequent to June 30, 2019, 33,973 $8,492 2019 Subsequent to June 30, 2019, $50,000 2019 15,000 $25,000 2019 7,500 Credit Facility with Co-borrower s On July 23, 2019, $1,500,000 5.5% July 23, 2019. Certain accredited investors are co-borrowers under the demand notes. The co-borrowers participating in this credit facility purchase 30,000 $100,000 may one one $0.15 five Subsequent to June 30, 2019, $400,000 5.5%. 120,000 may 2,666,667 $0.15

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2019
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation: 10 8 03 X not not December 31, 2018 2018 10
Consolidation, Policy [Policy Text Block]	Consolidation: 56% June 30, 2019,
Use of Estimates, Policy [Policy Text Block]	Use of Estimates:
Reclassification, Policy [Policy Text Block]	Reclassifications: may
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash: may $5,000.
Inventory, Policy [Policy Text Block]	Inventory June 30, 2019 December 31, 2018 $ 1,747,000
Depreciation, Depletion, and Amortization [Policy Text Block]	Depreciation and amortization: three six June 30, 2019 2018 Three months ended June 30, 2019 Six months ended June 30, 2019 Three months ended June 30, 2018 Six months ended June 30, 2018 Right-to use building $ 25,000 $ 52,000 - - Software 2,000 6,000 $ 31,000 $ 62,000 Property and equipment 7,000 14,000 13,000 26,000 $ 34,000 $ 72,000 $ 44,000 $ 88,000
Lessee, Leases [Policy Text Block]	Right to use building asset: No. 2016 02, The standard became effective for the Company January 1, 2019. not not no
Software Property And Equipment [Policy Text Block]	Software, Property and Equipment: Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term Betterments, renewals and significant repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense). Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may
Fair Value Measurement, Policy [Policy Text Block]	Fair Value of Financial Instruments: , one three Level 1: Level 2: Level 3: not The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 3 June 30, 2019 December 31, 2018. $4,354,000 June 30, 2019 June 30, 2019.
Revenue [Policy Text Block]	Revenue Recognition and Deferred Revenue: January 1, 2018, 606, no 606. two The Company's net revenue is derived primarily from domestic customers. For the six June 30, 2019 $9,000 no three June 30, 2019 $2,000 no 100% three June 30, 2019. 30 CURA revenue is recognized (a) upon receipt of payment at the point of sale of the CURA app, (b) upon the delivery of myCadian products and (c) upon the company’s satisfaction of all performance obligations as described in customer agreements. The Z-Coach Program provides fatigue training over an annual subscription period of twelve 30
In Process Research and Development, Policy [Policy Text Block]	Engineering and Development and Patents: six June 30, 2019 2018 $21,000 $56,000, three June 30, 2019 2018 $11,000 $25,000,
Share-based Payment Arrangement [Policy Text Block]	Stock-based Compensation: 718 10 may 718 10. No During 2018, 2018 07, 718 20 January 1, 2018 $10,000
Income Tax, Policy [Policy Text Block]	Income Taxes: not not We account for uncertain tax positions using a more-likely-than- not not not June 30, 2019, December 31, 2018, no
Earnings Per Share, Policy [Policy Text Block]	Loss per Common Share: 260 10 June 30, 2019 2018, 99,159,056 87,941,132 625,000 June 30, 2019 2018 not

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2019
Notes Tables
Depreciation and Amortization [Table Text Block]	Three months ended June 30, 2019 Six months ended June 30, 2019 Three months ended June 30, 2018 Six months ended June 30, 2018 Right-to use building $ 25,000 $ 52,000 - - Software 2,000 6,000 $ 31,000 $ 62,000 Property and equipment 7,000 14,000 13,000 26,000 $ 34,000 $ 72,000 $ 44,000 $ 88,000
Software, Property and Equipment Estimated Useful Life [Table Text Block]	Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term

Note 3 - Inventory and Relate_2

Note 3 - Inventory and Related Vendor Liability (Tables)	6 Months Ended
	Jun. 30, 2019
Notes Tables
Schedule of Inventory, Current [Table Text Block]	June 30, 2019 December 31, 2018 Raw materials $ 1,678,000 $ 1,678,000 Finished goods 69,000 69,000 1,747,000 1,747,000 Less: Reserve for quality (1,747,000 ) (1,747,000 ) Inventory (net) $ - $ - Liability for inventory $ 1,477,000 $ 1,462,000

Note 4 - Senior Convertible N_2

Note 4 - Senior Convertible Notes and Warrants (Tables)	6 Months Ended
	Jun. 30, 2019
Notes Tables
Convertible Debt [Table Text Block]	Total 2019 6% Notes JULY 2018 Notes 2018 Notes 2017 6% Notes 2016 6% Notes Face value December 31, 2018 $ 9,160,000 $ - $ 1,175,000 $ 625,000 $ 4,370,000 $ 2,990,000 Notes issued in current period 800,000 300,000 500,000 - - - Face value June 30, 2019 $ 9,960,000 $ 300,000 $ 1,675,000 $ 625,000 $ 4,370,000 $ 2,990,000 Debt discount December 31, 2018 $ (2,557,000 ) $ - $ (360,000 ) $ (231,000 ) $ (456,000 ) $ (1,510,000 ) Debt discount issued in current period (82,000 ) (17,000 ) (65,000 ) - - - Amortization of discount reported as interest 351,000 3,000 32,000 22,000 41,000 253,000 Debt discount June 30, 2019 $ (2,288,000 ) $ (14,000 ) $ (393,000 ) $ (209,000 ) $ (415,000 ) $ (1,257,000 ) Senior Convertible Notes (net) $ 7,672,000 $ 286,000 $ 1,282,000 $ 416,000 $ 3,955,000 $ 1,733,000

Note 8 - Property and Equipme_2

Note 8 - Property and Equipment (Tables)	6 Months Ended
	Jun. 30, 2019
Notes Tables
Property, Plant and Equipment [Table Text Block]	June 30, 2019 December 31, 2018 Office equipment $ 249,000 $ 249,000 Shop equipment 182,000 182,000 Leasehold improvements 253,000 253,000 684,000 684,000 Less accumulated depreciation (636,000 ) (622,000 ) Net property and equipment $ 48,000 $ 62,000

Note 9 - Business Segments (Tab

Note 9 - Business Segments (Tables)	6 Months Ended
	Jun. 30, 2019
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	CURA Aegis Corporate Total Revenue $ 2,000 $ - $ - $ 2,000 Loss on revenue (1,000 ) - - (1,000 ) Total costs and expenses 176,000 150,000 335,000 661,000 Loss from operations (177,000 ) (150,000 ) (335,000 ) (662,000 ) Interest and other - - (303,000 ) (303,000 ) Net loss $ (177,000 ) $ (150,000 ) $ (638,000 ) $ (965,000 ) Stock based compensation $ 6,000 $ 5,000 $ 34,000 $ 45,000 Depreciation and amortization $ 3,000 $ 5,000 $ 26,000 $ 34,000 Assets at June 30, 2019 $ 6,000 $ 45,000 $ 246,000 $ 297,000 CURA Aegis Corporate Total Revenue $ 9,000 $ - $ - $ 9,000 Loss on revenue - - - - Total costs and expenses 515,000 319,000 702,000 1,536,000 Loss from operations (515,000 ) (319,000 ) (702,000 ) (1,536,000 ) Interest and other - - (577,000 ) (577,000 ) Net loss $ (515,000 ) $ (319,000 ) $ (1,279,000 ) $ (2,113,000 ) Stock based compensation $ 14,000 $ 13,000 $ 77,000 $ 104,000 Depreciation and amortization $ 9,000 $ 10,000 $ 53,000 $ 72,000 Assets at June 30, 2019 $ 6,000 $ 45,000 $ 246,000 $ 297,000 CURA Aegis Corporate Total Revenue $ 8,000 $ - $ - $ 8,000 Loss on revenue (25,000 ) - - (25,000 ) Total costs and expenses 373,000 160,000 325,000 858,000 Loss from operations (398,000 ) (160,000 ) (325,000 ) (883,000 ) Interest and other expense - - (259,000 ) (259,000 ) Net loss $ (398,000 ) $ (160,000 ) $ (584,000 ) $ (1,142,000 ) Stock based compensation $ 5,000 $ 26,000 $ 4,000 $ 35,000 Depreciation and amortization $ 37,000 $ 5,000 $ 2,000 $ 44,000 Assets at June 30, 2018 $ 1,810,000 $ 65,000 $ 144,000 $ 2,019,000 CURA Aegis Corporate Total Revenue $ 16,000 $ - $ - $ 16,000 Loss on revenue (54,000 ) - - (54,000 ) Total costs and expenses 896,000 291,000 701,000 1,888,000 Loss from operations (950,000 ) (291,000 ) (701,000 ) (1,942,000 ) Interest and other expense - - (495,000 ) (495,000 ) Net loss $ (950,000 ) $ (291,000 ) $ (1,196,000 ) $ (2,437,000 ) Stock based compensation $ (11,000 ) $ 28,000 $ 20,000 $ 37,000 Depreciation and amortization $ 74,000 $ 10,000 $ 4,000 $ 88,000 Assets at June 30, 2018 $ 1,810,000 $ 65,000 $ 144,000 $ 2,019,000

Note 11 - Stock Options (Tables

Note 11 - Stock Options (Tables)	6 Months Ended
	Jun. 30, 2019
Notes Tables
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	2019 2018 Expected term (years) - 6.3 Expected forfeiture rate - 0% Risk-free rate - 2.6% Volatility - 130% Dividend yield - 0.0%
Share-based Payment Arrangement, Option, Activity [Table Text Block]	Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term (years) Value Outstanding at January 1, 2019 11,028,500 $ 0.49 3.8 $ 94,000 Granted - - Exercised - - Canceled or expired - - Outstanding at June 30, 2019 11,028,500 $ 0.49 3.3 $ - Exercisable at June 30, 2019 7,314,000 $ 0.56 2.7 $ -

Note 12 - Warrants (Tables)

Note 12 - Warrants (Tables)	6 Months Ended
	Jun. 30, 2019
Notes Tables
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Weighted Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 1, 2019 7,381,707 $ 0.46 (A) 7.0 (B) $ 39,000 Granted 350,000 0.25 Exercised - - Canceled or expired - - Outstanding at June 30, 2019 7,731,707 $ 0.45 (A) 6.7 (B) $ 27,000 Exercisable at June 30, 2019 7,106,707 $ 0.44 6.2 (C) $ 27,000

Note 1 - The Company and Basi_2

Note 1 - The Company and Basis of Presentation (Details Textual)	6 Months Ended
	Jun. 30, 2019USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Jun. 30, 2018USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2017USD ($)
Number of Operating Segments	2
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 36,000		$ 53,000	$ 89,000		$ 194,000
Working Capital	(3,161,000)
Stockholders' Equity Attributable to Parent, Ending Balance	(10,393,000)	$ (9,497,000)	(8,479,000)	$ (5,318,000)	$ (4,482,000)	$ (3,408,000)
Retained Earnings (Accumulated Deficit), Ending Balance	(89,262,000)		$ (87,149,000)
Proceeds From Convertible Debt, Gross	1,225,000
Maximum [Member]
Cash Needed During the Year to Fund Current and Future Commitments	2,500,000
Minimum [Member]
Cash Needed During the Year to Fund Current and Future Commitments	$ 3,000,000

Note 2 - Summary of Significa_3

Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($)	Jan. 01, 2018	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Inventory Valuation Reserves, Ending Balance		$ 1,747,000		$ 1,747,000		$ 1,747,000
Revenue from Contract with Customer, Including Assessed Tax		2,000	$ 8,000	9,000	$ 16,000
Excess Tax Benefit from Share-based Compensation, Operating Activities				0
Share-based Payment Arrangement, Expense		45,000	35,000	104,000	$ 37,000
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total		0		$ 0		$ 0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount				99,159,056	87,941,132
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount				625,000	625,000
Accounting Standards Update 2018-07 [Member] | Share-based Payment Arrangement, Option [Member]
Share-based Payment Arrangement, Expense	$ (10,000)
General and Administrative Expense [Member]
Patent Cost		$ 11,000	$ 25,000	$ 21,000	$ 56,000
Z-Coach Aviation Wellness Program Annual Subscription [Member]
Deferred Revenue Arrangement, Subscription Period				1 year
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member]
Concentration Risk, Percentage		100.00%
Transferred over Time [Member]
Revenue from Contract with Customer, Including Assessed Tax		$ 2,000		$ 9,000
Transferred at Point in Time [Member]
Revenue from Contract with Customer, Including Assessed Tax		0		0
Senior Convertible Promissory Notes [Member]
Long-term Debt, Fair Value		4,354,000		4,354,000
Commercial Paper [Member] | Collateral Pledged [Member]
Debt Instrument, Collateral Amount		$ 5,000		$ 5,000
Subsidiaries [Member]
Equity Method Investment, Ownership Percentage		56.00%		56.00%

Note 2 - Summary of Significa_4

Note 2 - Summary of Significant Accounting Policies - Depreciation and Amortization (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Depreciation and amortization	$ 34,000	$ 44,000	$ 72,000	$ 88,000
Right-to-use Building [Member]
Depreciation and amortization	25,000		52,000
Software Development [Member]
Depreciation and amortization	2,000	31,000	6,000	62,000
Property and Equipment [Member]
Depreciation and amortization	$ 7,000	$ 13,000	$ 14,000	$ 26,000

Note 2 - Summary of Significa_5

Note 2 - Summary of Significant Accounting Policies - Property, and Equipment, Estimated Useful Lives (Details)	6 Months Ended
	Jun. 30, 2019
Office Equipment [Member] | Minimum [Member]
Property plant and equipment, useful lives (Year)	5 years
Office Equipment [Member] | Maximum [Member]
Property plant and equipment, useful lives (Year)	7 years
Leasehold Improvements [Member]
Property plant and equipment, useful lives	lesser of useful life or lease term
Computer Software, Intangible Asset [Member]
Property plant and equipment, useful lives (Year)	3 years

Note 3 - Inventory and Relate_3

Note 3 - Inventory and Related Vendor Liability (Details Textual) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Inventory Valuation Reserves, Ending Balance	$ 1,747,000	$ 1,747,000
Liability for Inventory Held at Vendor	$ 1,477,000	$ 1,462,000

Note 3 - Inventory and Relate_4

Note 3 - Inventory and Related Vendor Liability - Inventory (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Raw materials	$ 1,678,000	$ 1,678,000
Finished goods	69,000	69,000
	1,747,000	1,747,000
Less: Reserve for quality	(1,747,000)	(1,747,000)
Inventory (net)
Liability for inventory	$ 1,477,000	$ 1,462,000

Note 4 - Senior Convertible N_3

Note 4 - Senior Convertible Notes and Warrants (Details Textual)	Jul. 24, 2018USD ($)$ / shares	May 08, 2018USD ($)$ / shares	Aug. 25, 2016$ / shares	Apr. 30, 2019USD ($)$ / shares	Jun. 30, 2019USD ($)shares	Jun. 30, 2018USD ($)	Jun. 30, 2019USD ($)shares	Jun. 30, 2018USD ($)	Dec. 31, 2018USD ($)	Nov. 30, 2018$ / shares	May 31, 2017$ / shares	Dec. 31, 2016USD ($)
Long-term Debt, Gross					$ 9,960,000		$ 9,960,000		$ 9,160,000
Debt Instrument, Unamortized Discount, Total					2,288,000		2,288,000		2,557,000
Long-term Debt, Total					7,672,000		7,672,000
Interest Expense, Total					304,000	$ 259,000	578,000	$ 496,000
Amortization of Debt Discount (Premium)							351,000	289,000
Proceeds from Convertible Debt							800,000
Increase in Unamortized Debt Discount Due to Issuance							82,000
Warrants Related to the 2017 Convertible Notes [Member]
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold											10.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares										$ 0.333
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes											25.00%
Warrants Related to the 2016 Convertible Notes [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.25
Warrants and Rights Outstanding, Term			10 years
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes			10.00%
Convertible Notes [Member]
Long-term Debt, Gross					9,960,000		9,960,000		9,160,000
Debt Instrument, Unamortized Discount, Total					2,288,000		2,288,000		2,557,000
Long-term Debt, Total					7,672,000		7,672,000		6,603,000
Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year					300,000		300,000
Long-term Debt, Maturities, Repayments of Principal in Year Two					0		0
Long-term Debt, Maturities, Repayments of Principal in Year Three					2,990,000		2,990,000
Long-term Debt, Maturities, Repayments of Principal in Year Four					2,775,500		2,775,500
Long-term Debt, Maturities, Repayments of Principal in Year Five					3,395,000		3,395,000
Long-term Debt, Maturities, Repayments of Principal after Year Five					500,000		500,000
Convertible Notes [Member] | Investor [Member]
Long-term Debt, Total					2,252,500		2,252,500		2,252,500
Convertible Notes [Member] | Affiliated Entity [Member]
Long-term Debt, Total					1,170,000		1,170,000		1,170,000
The 2019 Convertible Notes [Member]
Long-term Debt, Gross					300,000		300,000
Debt Instrument, Unamortized Discount, Total					14,000		14,000
Long-term Debt, Total					$ 286,000		$ 286,000
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement				$ 2,500,000
Debt Instrument, Interest Rate, Stated Percentage				6.00%
Debt Instrument, Term, Number of Days after Substantial Sale of Aegis Division				5 days
Debt Instrument, Term				5 years
Debt Instrument, Convertible, Conversion Price | $ / shares				$ 0.15
Debt Instrument, Convertible, Number of Equity Instruments				30,000
Debt Instrument, Convertible, Threshold Amount Needed to Invest to Convert a Specified Number of Equity Instruments				$ 100,000
Stock Issued During Period, Shares, New Issues | shares					90,000		90,000
Debt Instrument, Fee Amount					$ 5,000		$ 5,000
Interest Expense, Total					4,000
Amortization of Debt Discount (Premium)					3,000		3,000
Proceeds from Convertible Debt							300,000
Increase in Unamortized Debt Discount Due to Issuance							17,000
July 2018 Convertible Notes [Member]
Long-term Debt, Gross					1,675,000		1,675,000		1,175,000
Debt Instrument, Unamortized Discount, Total					393,000		393,000		360,000
Long-term Debt, Total					1,282,000		1,282,000
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement	$ 2,500,000
Debt Instrument, Term	5 years
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 0.25
Amortization of Debt Discount (Premium)					19,000	0	32,000	0
Proceeds from Convertible Debt							500,000
Increase in Unamortized Debt Discount Due to Issuance							65,000
Warrants Related to July 2018 Convertible Notes [Member]
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold	10.00%
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Above Investment Threshold	25.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 0.25
Warrants and Rights Outstanding, Term	10 years
The 2018 Convertible Notes [Member]
Long-term Debt, Gross					625,000		625,000		625,000
Debt Instrument, Unamortized Discount, Total					209,000		209,000		231,000
Long-term Debt, Total					416,000		416,000
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement		$ 1,000,000
Debt Instrument, Term		5 years
Debt Instrument, Convertible, Conversion Price | $ / shares		$ 0.25
Amortization of Debt Discount (Premium)					11,000	2,000	22,000	2,000
Proceeds from Convertible Debt
Increase in Unamortized Debt Discount Due to Issuance
Warrants Related to the 2018 Convertible Notes [Member]
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold		10.00%
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Above Investment Threshold		25.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.25
Warrants and Rights Outstanding, Term		10 years
The 2017 Convertible Notes [Member]
Long-term Debt, Gross					4,370,000		4,370,000		4,370,000
Debt Instrument, Unamortized Discount, Total					415,000		415,000		$ 456,000
Long-term Debt, Total					3,955,000		3,955,000
Debt Instrument, Interest Rate, Stated Percentage									6.00%
Debt Instrument, Term									5 years
Debt Instrument, Convertible, Conversion Price | $ / shares										$ 0.333	$ 0.50
Interest Expense, Total					91,000	92,000	171,000	166,000
Amortization of Debt Discount (Premium)					26,000	28,000	41,000	48,000
Proceeds from Convertible Debt
Increase in Unamortized Debt Discount Due to Issuance
The 2017 Convertible Notes [Member] | Maximum [Member]
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement									$ 5,000,000
The 2016 Convertible Notes [Member]
Long-term Debt, Gross					2,990,000		2,990,000		2,990,000
Debt Instrument, Unamortized Discount, Total					1,257,000		1,257,000		$ 1,510,000
Long-term Debt, Total					1,733,000		1,733,000
Debt Instrument, Interest Rate, Stated Percentage												6.00%
Debt Instrument, Term			5 years
Debt Instrument, Convertible, Conversion Price | $ / shares			$ 0.25
Interest Expense, Total					172,000	165,000	342,000	328,000
Amortization of Debt Discount (Premium)					$ 127,000	$ 120,000	253,000	$ 238,000
Proceeds from Convertible Debt
Increase in Unamortized Debt Discount Due to Issuance
The 2016 Convertible Notes [Member] | Maximum [Member]
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement												$ 3,000,000

Note 4 - Senior Convertible N_4

Note 4 - Senior Convertible Notes and Warrants - Schedule of Senior Convertible Notes Outstanding (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Face value			$ 9,160,000
Notes issued in current period			800,000
Face value	$ 9,960,000		9,960,000
Debt discount			(2,557,000)
Debt discount issued in current period			(82,000)
Amortization of discount reported as interest			351,000	$ 289,000
Debt discount	(2,288,000)		(2,288,000)
Senior Convertible Notes (net)	7,672,000		7,672,000
The 2019 Convertible Notes [Member]
Face value
Notes issued in current period			300,000
Face value	300,000		300,000
Debt discount
Debt discount issued in current period			(17,000)
Amortization of discount reported as interest	3,000		3,000
Debt discount	(14,000)		(14,000)
Senior Convertible Notes (net)	286,000		286,000
July 2018 Convertible Notes [Member]
Face value			1,175,000
Notes issued in current period			500,000
Face value	1,675,000		1,675,000
Debt discount			(360,000)
Debt discount issued in current period			(65,000)
Amortization of discount reported as interest	19,000	$ 0	32,000	0
Debt discount	(393,000)		(393,000)
Senior Convertible Notes (net)	1,282,000		1,282,000
The 2018 Convertible Notes [Member]
Face value			625,000
Notes issued in current period
Face value	625,000		625,000
Debt discount			(231,000)
Debt discount issued in current period
Amortization of discount reported as interest	11,000	2,000	22,000	2,000
Debt discount	(209,000)		(209,000)
Senior Convertible Notes (net)	416,000		416,000
The 2017 Convertible Notes [Member]
Face value			4,370,000
Notes issued in current period
Face value	4,370,000		4,370,000
Debt discount			(456,000)
Debt discount issued in current period
Amortization of discount reported as interest	26,000	28,000	41,000	48,000
Debt discount	(415,000)		(415,000)
Senior Convertible Notes (net)	3,955,000		3,955,000
The 2016 Convertible Notes [Member]
Face value			2,990,000
Notes issued in current period
Face value	2,990,000		2,990,000
Debt discount			(1,510,000)
Debt discount issued in current period
Amortization of discount reported as interest	127,000	$ 120,000	253,000	$ 238,000
Debt discount	(1,257,000)		(1,257,000)
Senior Convertible Notes (net)	$ 1,733,000		$ 1,733,000

Note 5 - Unsecured Subordinat_2

Note 5 - Unsecured Subordinated Promissory Notes (Details Textual) - USD ($)	6 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Short-term Debt, Total	$ 425,000
Unsecured Subordinated Promissory Notes [Member]
Short-term Debt, Total	$ 425,000
Debt Instrument, Interest Rate, Stated Percentage	6.00%
Debt Instrument, Term	90 days

Note 6 - Right-to-use Buildin_2

Note 6 - Right-to-use Building Asset (Details Textual) - USD ($)	3 Months Ended
	Jun. 30, 2019	Mar. 31, 2019	Jan. 01, 2019
Operating Lease, Liability, Total			$ 257,000
Lessee, Operating Lease, Discount Rate	6.00%
Operating Lease, Cost	$ 30,000	$ 30,000
Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year	105,000
Lessee, Operating Lease, Liability, Payments, Due Year Two	114,000
Lessee, Operating Lease, Liability, Payments, Due Year Three	47,000
Lessee, Operating Lease, Liability, Payments, Due, Total	267,000
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	$ 20,000

Note 7 - Software (Details Text

Note 7 - Software (Details Textual) - USD ($)	6 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Capitalized Computer Software, Net, Ending Balance	$ 4,000	$ 10,000
Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year	$ 4,000
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Asset, Useful Life	3 years

Note 8 - Property and Equipme_3

Note 8 - Property and Equipment - Property and Equipment (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Office equipment	$ 249,000	$ 249,000
Shop equipment	182,000	182,000
Leasehold improvements	253,000	253,000
	684,000	684,000
Less accumulated depreciation	(636,000)	(622,000)
Net property and equipment	$ 48,000	$ 62,000

Note 9 - Business Segments (Det

Note 9 - Business Segments (Details Textual)	6 Months Ended
	Jun. 30, 2019
Number of Operating Segments	2

Note 9 - Business Segments - Op

Note 9 - Business Segments - Operation by Segments (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2018	Mar. 31, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Revenue	$ 2,000		$ 8,000		$ 9,000	$ 16,000
Earnings (loss) on revenue	(1,000)		(25,000)			(54,000)
Total costs and expenses	661,000		858,000		1,536,000	1,888,000
Loss from operations	(662,000)		(883,000)		(1,536,000)	(1,942,000)
Interest and other	(303,000)		(259,000)		(577,000)	(495,000)
Net loss	(965,000)	$ (1,148,000)	(1,142,000)	$ (1,295,000)	(2,113,000)	(2,437,000)
Stock based compensation	45,000		35,000		104,000	37,000
Depreciation and amortization	34,000		44,000		72,000	88,000
Assets	297,000		2,019,000		297,000	2,019,000	$ 150,000
Operating Segments [Member] | CURA Division [Member]
Revenue	2,000		8,000		9,000	16,000
Earnings (loss) on revenue	(1,000)		(25,000)			(54,000)
Total costs and expenses	176,000		373,000		515,000	896,000
Loss from operations	(177,000)		(398,000)		(515,000)	(950,000)
Interest and other
Net loss	(177,000)		(398,000)		(515,000)	(950,000)
Stock based compensation	6,000		5,000		14,000	(11,000)
Depreciation and amortization	3,000		37,000		9,000	74,000
Assets	6,000		1,810,000		6,000	1,810,000
Operating Segments [Member] | Aegis Division [Member]
Revenue
Earnings (loss) on revenue
Total costs and expenses	150,000		160,000		319,000	291,000
Loss from operations	(150,000)		(160,000)		(319,000)	(291,000)
Interest and other
Net loss	(150,000)		(160,000)		(319,000)	(291,000)
Stock based compensation	5,000		26,000		13,000	28,000
Depreciation and amortization	5,000		5,000		10,000	10,000
Assets	45,000		65,000		45,000	65,000
Corporate, Non-Segment [Member]
Revenue
Earnings (loss) on revenue
Total costs and expenses	335,000		325,000		702,000	701,000
Loss from operations	(335,000)		(325,000)		(702,000)	(701,000)
Interest and other	(303,000)		(259,000)		(577,000)	(495,000)
Net loss	(638,000)		(584,000)		(1,279,000)	(1,196,000)
Stock based compensation	34,000		4,000		77,000	20,000
Depreciation and amortization	26,000		2,000		53,000	4,000
Assets	$ 246,000		$ 144,000		$ 246,000	$ 144,000

Note 10 - Preferred and Commo_2

Note 10 - Preferred and Common Stock (Details Textual) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Common stock, shares authorized (in shares)	400,000,000	400,000,000		400,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01		$ 0.01
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000		100,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01		$ 0.01
Series C3 Preferred Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities			870,000
Preferred stock, shares outstanding (in shares)	3,268,000	3,268,000		3,268,000
Preferred Class A [Member]
Preferred stock, shares outstanding (in shares)	468,221	468,221		468,221
Preferred Stock, Shares Outstanding, Not Accruing Dividends	8,709	8,709
Preferred Stock, Shares Outstanding, Accruing Dividends	459,512	459,512
Dividends Payable	$ 2,621,000	$ 2,621,000		$ 2,530,000
Preferred Stock, Liquidation Preference, Value	$ 2,621,000	$ 2,621,000		$ 2,530,000
Preferred Stock, Liquidation Preference Per Share	$ 4	$ 4
Preferred Class B [Member]
Preferred stock, shares outstanding (in shares)	67,500	67,500		67,500
Dividends Payable	$ 471,000	$ 471,000		$ 454,000
Preferred Stock, Liquidation Preference, Value	$ 471,000	$ 471,000		$ 454,000
Preferred Stock, Liquidation Preference Per Share	$ 5	$ 5
Series C Preferred Stock [Member]
Preferred stock, shares outstanding (in shares)	15,687,500	15,687,500		15,687,500
Preferred Stock, Liquidation Preference, Value	$ 6,275,000	$ 6,275,000		$ 6,275,000
Preferred Stock, Liquidation Preference Per Share	$ 0.40	$ 0.40
Series C2 Preferred Stock [Member]
Preferred stock, shares outstanding (in shares)	24,500,000	24,500,000		24,500,000
Preferred Stock, Liquidation Preference, Value	$ 4,900,000	$ 4,900,000		$ 4,900,000
The 2016 and 2017 Convertible Note [Member]
Stock Issued During Period, Shares, New Issues		75,152
Shares Issued, Price Per Share	$ 0.25	$ 0.25
The 2019 Convertible Notes [Member]
Stock Issued During Period, Shares, New Issues	90,000	90,000

Note 11 - Stock Options (Detail

Note 11 - Stock Options (Details Textual) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2011	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Share-based Payment Arrangement, Expense	$ 45,000	$ 35,000	$ 104,000	$ 37,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total	$ 193,000		$ 193,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition			1 year
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value			$ 0	$ 0.25
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value			$ 74,000	$ 259,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period			0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total			0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period				391,875
Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit			$ 0.22
Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit			$ 1.58
Stock Option Plan 2016 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized						3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			1,220,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	1,780,000		1,780,000
Stock Option Plan 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized					3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0	917,500	0	1,067,500
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	91,500		91,500
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum					10.00%
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date					110.00%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period					10 years

Note 11 - Stock Options - Stock

Note 11 - Stock Options - Stock Options Valuation Assumptions (Details)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Expected term (years) (Year)		6 years 109 days
Expected forfeiture rate		0.00%
Risk-free rate		2.60%
Volatility		130.00%
Dividend yield		0.00%

Note 11 - Stock Options - Share

Note 11 - Stock Options - Share-based Compensation, Stock Options, Activity (Details) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Outstanding shares (in shares)	11,028,500
Outstanding - weighted average exercise price (in dollars per share)	$ 0.49
Outstanding - weighted average remaining contractual term (Year)	3 years 109 days		3 years 292 days
Outstanding - aggregate intrinsic value			$ 94,000
Shares, granted (in shares)
Weighted average exercise price, granted (in dollars per share)
Shares, exercised (in shares)	0	0
Weighted average exercise price, exercised (in dollars per share)
Shares, canceled or expired (in shares)	0
Weighted average exercise price, canceled or expired (in dollars per share)
Outstanding shares (in shares)	11,028,500		11,028,500
outstanding - weighted average exercise price (in dollars per share)	$ 0.49		$ 0.49
Shares, exercisable (in shares)	7,314,000
Weighted average exercise price, exercisable (in dollars per share)	$ 0.56
Exercisable- weighted average remaining contractual term (Year)	2 years 255 days
Exercisable-aggregate intrinsic value

Note 12 - Warrants (Details Tex

Note 12 - Warrants (Details Textual) - shares	Jun. 30, 2019	Dec. 31, 2018	Jun. 30, 2018
Class of Warrant or Right, Outstanding	7,731,707	7,381,707
Warrants without Expiration Date, Outstanding	743,500		743,500
Warrants without Expiration Date, Exercisable	118,500		118,500
Warrants Not Determined, Exercise Price [Member]
Class of Warrant or Right, Outstanding			1,750,000

Note 12 - Warrants - Summary of

Note 12 - Warrants - Summary of Outstanding Warrants (Details) - USD ($)		6 Months Ended	12 Months Ended
		Jun. 30, 2019	Dec. 31, 2018
Shares outstanding (in shares)		7,381,707
Outstanding, weighted average exercise price (in dollars per share)	[1]	$ 0.46
Outstanding, weighted average remaining contractual term (Year)	[2]	6 years 255 days	7 years
Outstanding, aggregate intrinsic value		$ 27,000	$ 39,000
Class of Warrant or Right, Issued During Period		350,000
Granted, weighted average exercise price (in dollars per share)		$ 0.25
Shares exercised (in shares)
Exercised, weighted average exercise price (in dollars per share)
Shares canceled or expired (in shares)
Canceled or expired, weighted average exercise price (in dollars per share)
Shares outstanding (in shares)		7,731,707	7,381,707
Outstanding, weighted average exercise price (in dollars per share)	[1]	$ 0.45	$ 0.46
Shares exercisable (in shares)		7,106,707
Exercisable, weighted average exercise price (in dollars per share)		$ 0.44
Exercisable, weighted average remaining contractual term (Year)	[3]	6 years 73 days
Exercisable, aggregate intrinsic value		$ 27,000
[1]	The weighted average exercise price for warrants outstanding as of June 30, 2019 and 2018 excludes 1,750,000 warrants in each period with no determined exercise price.
[2]	The weighted average remaining contractual term for warrants outstanding as of June 30, 2019 and 2018 excludes 743,500 warrants with no expiration date.
[3]	The weighted average remaining contractual term for warrants exercisable as of June 30, 2019, and 2018 excludes 118,500 warrants with no expiration date.

Note 13 - Related Party Trans_2

Note 13 - Related Party Transactions (Details Textual)	May 08, 2018	Jun. 30, 2019USD ($)shares	Jun. 30, 2019USD ($)shares	Jun. 30, 2018USD ($)	Dec. 31, 2018USD ($)shares
Proceeds from Short-term Debt, Total			$ 425,000
The 2018 Convertible Notes [Member]
Debt Instrument, Term	5 years
Six Members of the Board of Directors [Member] | Warrants Related to the 2018 Convertible Notes [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		1,239,288	1,239,288		1,239,288
Six Members of the Board of Directors [Member] | The 2018 Convertible Notes [Member]
Debt Instrument, Face Amount		$ 2,252,500	$ 2,252,500		$ 2,252,500
Debt Instrument, Convertible, Number of Equity Instruments			7,888,378		7,888,378
Chief Executive Officer [Member] | Unsecured Subordinated Promissory Notes [Member]
Proceeds from Short-term Debt, Total		$ 425,000
Debt Instrument, Term			90 days
Debt Instrument, Interest Rate, Stated Percentage		6.00%	6.00%

Note 14 - Subsequent Events (De

Note 14 - Subsequent Events (Details Textual)	Aug. 08, 2019USD ($)shares	Jul. 23, 2019USD ($)$ / shares	Aug. 08, 2019USD ($)$ / sharesshares	Apr. 30, 2019USD ($)$ / shares	Jun. 30, 2019USD ($)shares	Mar. 31, 2019USD ($)	Jun. 30, 2019USD ($)shares	Jul. 11, 2019USD ($)	Dec. 31, 2018USD ($)
Stock Issued During Period, Value, Interest					$ 10,000	$ 8,000
Long-term Debt, Gross					$ 9,960,000		$ 9,960,000		$ 9,160,000
Class of Warrant or Right, Issued During Period | shares							350,000
Unsecured Subordinated Promissory Notes [Member] | Chief Executive Officer [Member]
Debt Instrument, Interest Rate, Stated Percentage					6.00%		6.00%
The 2019 Convertible Notes [Member]
Debt Instrument, Interest Rate, Stated Percentage				6.00%
Long-term Debt, Gross					$ 300,000		$ 300,000
Stock Issued During Period, Shares, New Issues | shares					90,000		90,000
Debt Instrument, Convertible, Number of Equity Instruments				30,000
Debt Instrument, Convertible, Threshold Amount Needed to Invest to Convert a Specified Number of Equity Instruments				$ 100,000
Debt Instrument, Convertible, Conversion Price | $ / shares				$ 0.15
Debt Instrument, Term, Number of Days after Substantial Sale of Aegis Division				5 days
Subsequent Event [Member]
Stock Issued During Period, Shares, Interest | shares			33,973
Stock Issued During Period, Value, Interest			$ 8,492
Subsequent Event [Member] | Unsecured Subordinated Promissory Notes [Member] | Chief Executive Officer [Member]
Debt Instrument, Face Amount								$ 50,000
Debt Instrument, Interest Rate, Stated Percentage								6.00%
Subsequent Event [Member] | The 2019 Convertible Notes [Member]
Long-term Debt, Gross	$ 50,000		50,000
Stock Issued During Period, Shares, New Issues | shares	15,000
Subsequent Event [Member] | The 2019 Convertible Notes [Member] | Director [Member]
Long-term Debt, Gross	$ 25,000		$ 25,000
Stock Issued During Period, Shares, New Issues | shares			7,500
Subsequent Event [Member] | Credit Facility with Co-borrowers [Member]
Debt Instrument, Interest Rate, Stated Percentage	5.50%		5.50%
Long-term Debt, Gross	$ 400,000		$ 400,000
Stock Issued During Period, Shares, New Issues | shares			120,000
Line of Credit Facility, Maximum Borrowing Capacity		$ 1,500,000
Debt Instrument, Convertible, Number of Equity Instruments		30,000
Debt Instrument, Convertible, Threshold Amount Needed to Invest to Convert a Specified Number of Equity Instruments		$ 100,000
Debt Instrument, Convertible, Conversion Price | $ / shares		$ 0.15
Debt Instrument, Term, Number of Days after Substantial Sale of Aegis Division		5 days
Subsequent Event [Member] | Credit Facility with Co-borrowers [Member] | Rights Related to Credit Facility with Co-borrowers [Member]
Class of Warrant or Right, Issued During Period | shares			2,666,667
Class of Warrant or Right, Issued During Period, Exercise Price | $ / shares			$ 0.15
Subsequent Event [Member] | Credit Facility with Co-borrowers [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate		5.50%